ARS Pharmaceuticals (SPRY) Asset Utilization Ratio (2022 - 2025)
Historic Asset Utilization Ratio for ARS Pharmaceuticals (SPRY) over the last 4 years, with Q3 2025 value amounting to 0.42.
- ARS Pharmaceuticals' Asset Utilization Ratio rose 346102.42% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year increase of 346102.42%. This contributed to the annual value of 0.31 for FY2024, which is 26160863.6% up from last year.
- As of Q3 2025, ARS Pharmaceuticals' Asset Utilization Ratio stood at 0.42, which was up 346102.42% from 0.35 recorded in Q2 2025.
- In the past 5 years, ARS Pharmaceuticals' Asset Utilization Ratio registered a high of 0.42 during Q3 2025, and its lowest value of 0.0 during Q1 2024.
- Over the past 4 years, ARS Pharmaceuticals' median Asset Utilization Ratio value was 0.0 (recorded in 2022), while the average stood at 0.09.
- Per our database at Business Quant, ARS Pharmaceuticals' Asset Utilization Ratio tumbled by 9821.79% in 2024 and then skyrocketed by 65948605.54% in 2025.
- Quarter analysis of 4 years shows ARS Pharmaceuticals' Asset Utilization Ratio stood at 0.0 in 2022, then plummeted by 97.39% to 0.0 in 2023, then soared by 251602.23% to 0.31 in 2024, then soared by 32.73% to 0.42 in 2025.
- Its Asset Utilization Ratio stands at 0.42 for Q3 2025, versus 0.35 for Q2 2025 and 0.29 for Q1 2025.